Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
17,659,276
-
Shares change
-
-547,807
-
Total reported value, excl. options
-
$118,497,474
-
Value change
-
-$4,034,573
-
Put/Call ratio
-
58%
-
Number of buys
-
34
-
Number of sells
-
-25
-
Price
-
$6.71
Significant Holders of AC Immune SA - SHS (ACIU) as of Q3 2021
78 filings reported holding ACIU - AC Immune SA - SHS as of Q3 2021.
AC Immune SA - SHS (ACIU) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,659,276 shares
.
Largest 10 shareholders include BVF INC/IL (6,935,179 shares), Avidity Partners Management LP (1,739,600 shares), PLATINUM INVESTMENT MANAGEMENT LTD (1,062,462 shares), Artal Group S.A. (1,000,000 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (963,500 shares), EcoR1 Capital, LLC (751,251 shares), Balyasny Asset Management LLC (733,180 shares), MORGAN STANLEY (555,703 shares), RENAISSANCE TECHNOLOGIES LLC (424,690 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (396,919 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.